- Previous Close
0.0460 - Open
0.0460 - Bid 0.0330 x --
- Ask 0.1150 x --
- Day's Range
0.0460 - 0.0460 - 52 Week Range
0.0110 - 0.2330 - Volume
5 - Avg. Volume
361 - Market Cap (intraday)
1.054M - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. The company offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. It also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.
www.egftheramedhealth.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: EVAHF
View MorePerformance Overview: EVAHF
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EVAHF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EVAHF
View MoreValuation Measures
Market Cap
1.06M
Enterprise Value
2.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-105.24%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-404.09k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
20.17k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
133.37k